Company: APXIF
Filing Date: 2025-06-11
Form Type: 10-Q
Source: 0001213900-25-053185
Chunk: 123

Company: APx Acquisition Corp. I
Filing Date: 2025-06-11
Form: 10-Q
Item: Part I, Item 8
Chunk 123
---
 to certain representations
and warranties, where the failure of such representations and warranties to be true and correct does not result in a SPAC Material Adverse
Effect; (b) the performance or compliance in all material respects with all agreements and covenants required by the Proposed Business
Combination Agreement; and (c) the absence of a SPAC Material Adverse Effect.

 33

While the obligation
of MultiplAI to consummate the Proposed Business Combination is subject to the consummation of the transactions contemplated by the MultiplAI
SPA, the obligations of the parties to the Business Combination Agreement (other than MultiplAI) to consummate the Proposed Business Combination
is not subject to the consummation of the transactions contemplated by the MultiplAI SPA.

Representations and Warranties

The Business Combination
Agreement contains customary representations and warranties of the Company, OmnigenicsAI, MultiplAI and Merger Sub relating to, among
other things, their ability to enter into the Business Combination Agreement and the other Transaction Documents to which they are party
and their outstanding capitalization. The representations and warranties of the parties contained in the Business Combination Agreement
will terminate and be of no further force and effect as of the Closing.

Covenants

The Business
Combination Agreement contains customary covenants of the parties, including, among others, covenants providing for (i) the
operation of the parties’ respective businesses prior to consummation of the Business Combination, (ii) the
parties’ efforts to satisfy conditions to consummate the Business Combination, (iii) the parties’ preparing and
OmnigenicsAI filing a registration statement containing a proxy statement/prospectus for the purpose of soliciting proxies from the
Company’s shareholders to vote in favor of certain matters and registering under the Securities Act of 1933, as amended (the
“Securities Act”) the Company Shares and Company Warrants to be issued in connection with the Merger,
(iv) the protection of, and access to, confidential information of the parties, (v) the parties’ efforts to obtain
necessary approvals from Governmental Authorities, and (vi) the parties’ efforts to obtain PIPE Investments. The
covenants of the parties contained in the Business Combination Agreement will terminate and be of no further force and effect as of
the Closing, except for those covenants that by their terms require performance after the Closing.

Termination

The Business